Deutsche Bank offices searched in money laundering probe

Weather - Sydney 18°C

Deutsche Bank offices searched in money laundering probe

ECONOMY 28.01.2026

Deutsche Bank offices searched in money laundering probe / Photo: © AFP

German prosecutors and police on Wednesday searched Deutsche Bank's headquarters in Frankfurt and its office in Berlin in an investigation over suspected money laundering offences, officials said.

Change text size:

According to the Sueddeutsche Zeitung daily, the probe is connected to suspected offences in the bank's dealings with companies linked to Russian billionaire businessman Roman Abramovich.

Prosecutors confirmed the raids at the premises of Germany's biggest bank but did not say who was being targeted.

The Frankfurt prosecutors' office said it was carrying out an "investigation into unknown responsible parties and employees of Deutsche Bank on suspicion of money laundering... and related additional allegations under the Anti-Money Laundering Act".

"In the past, Deutsche Bank maintained business relationships with foreign companies that... are themselves suspected of having been used for the purpose of money laundering," a spokesman for the office said in a statement to AFP.

It said the investigation was being carried out by a specialist economic crime unit along with the federal police.

A spokesman for Deutsche Bank confirmed the searches, and the bank said it was "cooperating fully with prosecutors" but refused to comment further.

According to financial sources, the probe relates to alleged offences committed between 2013 and 2018.

The raids come on the eve of the publication of the bank's results for the fourth quarter of 2025.

- Legal scrutiny -

Abramovich has been sanctioned by the EU following Russia's invasion of Ukraine.

Sueddeutsche Zeitung said Deutsche Bank was being investigated on suspicion of failing to report possible money laundering in a timely manner.

The daily reported that the investigation involves both payments that Deutsche Bank received via a Russian correspondent account and the bank's previous dealings with Abramovich's own companies.

According to news site Der Spiegel the search in Frankfurt involved around 30 plainclothes investigators.

Deutsche Bank has faced scrutiny on several occasions in recent years over suspicious transactions.

In 2022 its offices were raided over "suspicious activity reports filed by the bank", again in relation to money laundering.

Media reports at the time said that the investigation centred on a transaction involving Rifaat al-Assad, the uncle of Syria's then leader Bashar al-Assad.

The Frankfurt-based group also came under scrutiny for its role as a correspondence bank that handled foreign transactions for Danske Bank's Estonian branch, at the centre of a 200-billion-euro ($212-billion) money-laundering affair between 2007 and 2015.

Deutsche Bank subsequently agreed to pay a fine of 13.5 million euros for failing to report suspicious activity quickly enough, after an investigation by Frankfurt prosecutors.

F.Harris--TNT

Featured

Carney touts Canada 'pivot' away from US as Trump levels new threat

Canadian Prime Minister Mark Carney said Tuesday that reducing economic ties with the United States would come at a cost but the benefits were clear, as President Donald Trump threatened new penalties targeting Canada.

Nearly 1,100 flights cancelled after UK air traffic control glitch

Almost 1,100 flights to and from UK airports were cancelled Tuesday due to what the country's air traffic control service called a technical issue, in the latest glitch to spark travel chaos.

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Change text size:

The National Times - Deutsche Bank offices searched in money laundering probe